News & Media: All

Apr 16, 2015

Precision for Medicine Acquires Precision Health Economics

Extends Leadership in Health Economics and Outcomes Research With a Focus on Evidence Generation in an Era of Precision Medicine

Bethesda, MD, and Los Angeles, April 16, 2015 – Precision for Medicine (Precision), a specialized services company supporting next-generation approaches to drug de ...

Apr 9, 2015

Dana Goldman at AMCP Expo: "Drug Pricing Viewed the Wrong Way"

Appearing at the AMCP's Annual Meeting and Expo in San Diego, CA, PHE Founding Partner Dana Goldman pointed out that the current model for drug pricing needs to evolve and should more closely resemble other forms of intellectual property pricing, like that of software operating systems for examp ...

Apr 8, 2015

PHE's Philipson and Stevens Anchor Special Health Affairs DC Cancer Briefling

PHE Founding Partner Tomas Philipson and Senior Research Economist Warren Stevens were both featured speakers appearing at the National Press Club in Washington, DC on April 7th-- participating in a special Health Affairs briefing organized to coincide with their special issue: "The Cost and Qul ...

Apr 3, 2015

Philipson in Forbes: Productivity Crises in Pharma?

In Tomas Philipson's latest Op-Ed, he examines the alleged productivity crises in Pharma (along with co-author Kristopher Hult).

To read the complete column, please click here.

Mar 18, 2015

Two PHE Abstracts Receive Awards at AMCP Annual Meeting

Kudos to two PHE teams that have received awards at the AMCP's Annual Meeting: authors Jason Shafrin, Joanna MacEwan, Avrita Campinha-Bacote, and John Romley were awarded the Platinum Medal for their abstract "Physician and Patient Preferences for Nonvalvular Atrial Fibrilation Therapies," and a ...

Mar 13, 2015

Tomas Philipson Named as Scientific Advisor by US House of Representatives

PHE is proud to announce that Founding Partner Tomas Philipson has been named as a Scientific Advisor by the US House of Representatives, selected to serve on the Energy and Commerce Committee's 21st Century Cures Initiative. This major bipartisan legislation is currently being formulated, and w ...

Mar 4, 2015

Philipson in Forbes: "Saving Lives Through Financial Innovation"

Tomas Philipson's latest Op-Ed column examines the cost of capital to conduct medical R & D: "Saving Lives Through Financial Innovation: FDA Swaps and Annuities"

To read the complete column, please click here.

Mar 3, 2015

Tomas Philipson Authors New Report for Milken Institute

A new report authored by PHE's founding partner Tomas Philipson on the Pipeline Risk in Pharma, presented to the Milken Institute, is now available online on the Institute's blog site, Currency of Ideas.

To read Dr. Philpson's complete report, please click here.

Feb 11, 2015

PHE Study Makes News; Julia Snider Participates in Special Health Affairs Briefing

A highly influential new study, recently published in a special edition of Health Affairs, has clarified the benefits and value of robotically-assisted surgery. Authored by PHE's Amitabh Chandra, Julia Thornton Snider, Dana Goldman, and Yanyu Wu, the paper illustrates that this dramatic form of ...

Feb 5, 2015

Philipson in Forbes: "Let Economists Perform Surgery?"

In Tomas Philipson's latest commentary, he suggests that just as you wouldn’t let a financial planner perform cancer surgery, we shouldn’t let physicians dictate complicated economic policy.

To read the complete article, please click here.

Jan 23, 2015

PHE's Work Cited In Wall Street Journal

A recent study published in the Journal of Parenteral and Enteral Nutrition, co-authored by PHE's Senior Research Economist Julia Thornton Snider, has been cited by Laura Landro in her article for The Wall Street Journal: "With Age Comes a Growing Risk of Malnutrition."

To read the complete WSJ ...

Jan 20, 2015

Spectrum of Dividends: A New Pespective on VBID

A new article just published in the American Journal of Managed Care (AJMC), co-authored by PHE's Chief Operating Officer Ross Maclean, provides new perspective on the Spectrum of Dividends criteria for VBID.

To read the complete article, please click here.

Jan 12, 2015

Philipson In Forbes: "Why World Inequality Is Falling and Not Rising"

In Tomas Philipson's first commentary for 2015, he examines the value of health into national measures of well-being such as GDP.

To read the full commentary, please click here.

Dec 8, 2014

Philipson in Forbes: Are Europeans Spending Too Little on Health Care?

In Tomas Philipson's latest Forbes commentary, "Are Europeans Spending Too Little on Health Care Compared to the US," he weighs survival rates compared to spending ratios for each system, illustrating some common misconceptions.

To read the complete article, please click here.

Nov 19, 2014

PHE's Goldman, Lakdawalla and Chandra in Harvard Business Review/New England Journal of Medicine

PHE Partners Dana Goldman and Darius Lakdawalla, along with Chief Scientific Officer Amitabh Chandra, offer their perspective on health care cost vs. value in a new article featured as a collaboration between the Harvard Business Review and The New England Journal of Medicine: "It's Easier to Me ...

Nov 17, 2014

PHE Senior Economist Snider Quoted in CNN Money

PHE's Senior Research Economist Julia Thornton Snider was quoted in CNN Money, commenting on her recent study establishing that people aged 65 and older, who were being treated for chronic obstructive pulmonary disease (COPD) in the hospital and received nutrition treatment (oral nutrition suppl ...

Nov 10, 2014

Philipson in Forbes: "Why No One On This Planet Has Health Insurance"

In Tomas Philipson's latest Op-Ed, he illustrates how medical innovation is the key to true "health insurance."

To read the article, please click here.

Nov 6, 2014

Dana Goldman's Forbes Guest Commentary: Give Vets Platinum Plans

In a special Forbes guest commentary by PHE Founding Partner Dana Goldman (along with co-author Martin Krieger), Dr. Goldman suggests that the VA would save money by offering veterans a private insurance-based platinum health plan.

To read the complete commentary, please click here.

Oct 31, 2014

UAE Cancer Congress 2014 Features Presentation by Tomas Philipson

On October 31st, the UAE Cancer Congress 2014 (held at the Grand Hyatt Dubai, UAE) welcomed Tomas Philipson as he addressed the state of healthcare technology assessement worldwide.

Dr. Philipson's presentation, part of the Introduction to Health Economics and Emerging Opportunities for the Mi ...

Oct 28, 2014

Philipson Participates in CanceRX Forum: Economics of Biomedical Innovation

On October 28th, 2014 PHE Founding Partner Tomas Philipson participated in the CanceRX conference, hosted by the Massachusetts Institute of Technology.  The invitation-only conference, focusing on new approached to commercializing biomedical research, spanned two days and included Dr. Philipson' ...

Oct 22, 2014

Darius Lakdawalla Quoted In Washington Post Blog

In Jason Millman's recent Washington Post blog, PHE Founding Partner Darius Lakdawalla was quoted on the subject of drug costs: "Why Extremely Expensive Drugs Are Often Worth the Cost."

To read the complete blog, click here.

Oct 6, 2014

Philipson In Forbes: Myths About Cancer Care

Tomas Philipson's latest Op-Ed in Forbes addresses some common misrepresentations in the policy community about cancer care in the US.

To read the complete article, please click here.